Navigating the CLL Treatment Field With Caution Q&A With Thomas Kipps, MD, PhD
Thomas Kipps, MD, PhD, discusses the chronic lymphocytic leukemia treatment spectrum and the explosion of targeted therapies in the field.
Weighing Fixed Duration Versus Continuous Therapy for CLL Q&A With Matthew S. Davids, MD, MMSc
Matthew S. Davids, MD, MMSc, discusses the rapid developments in the chronic lymphocytic leukemia treatment landscape.
New Data and Approvals Are Changing the Chronic Lymphocytic Leukemia Treatment Landscape
The treatment spectrum for chronic lymphocytic leukemia has expanded significantly with the development and approval of several new agents.
